Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Determination of optimized oxygen partial pressure to maximize the liver regenerative potential of the secretome obtained from adipose-derived stem cells

Fig. 1

Effects of various concentrations of culture pO2 on the microenvironment of ASCs. a Real-time RT-PCR showed mRNA expression of the markers for liver regeneration (IL-6, HGF, and VEGF) according to different concentrations of culture pO2. mRNA expression of these markers was significantly higher in AML12 cells cultured under 1% pO2 than in AML12 cells cultured under other pO2 concentrations. b Western blot analysis showed highest expression of HGF and VEGF in the 1% pO2 group. c ELISA showed the highest concentration of IL-6 in the 1% pO2 group. d Effects of secretome cultured under 21%, 10%, 5%, and 1% pO2 on proliferation of AML12 hepatocytes. AML12 cells cultured with secretome of 1% pO2 showed the highest cell proliferation, followed by cells cultured with secretome of 21%, 10%, and 5% pO2, in that order. e Effects of secretome with culture 1% pO2 on injured AML12 hepatocytes. Western blot analysis showed that supplementation with 1% pO2 secretome significantly increased expression levels of PCNA and p-STAT3 better than 21% pO2 secretome. f Effects of the secretome with culture 1% pO2 on injured TCMK-1 renal cells. Western blot analysis showed that supplementation with 21% pO2 secretome significantly increased the expression levels of PCNA and p-STAT3 better than the 1% pO2 secretome. Data show mean and SD for three independent experiments. *p < 0.05 compared to control. ASC adipose-derived stem cell, Ct control, HGF hepatocyte growth factor, IL interleukin, IR ischemia–reperfusion, PCNA proliferating cell nuclear antigen, pO 2 oxygen partial pressure, p-STAT3 phospho-signal transducer and activator of transcription 3, S21% secretome of culture 21% pO2, S10% secretome of culture 10% pO2, S5% secretome of culture 5% pO2, S1% secretome of culture 1% pO2, VEGF vascular endothelial cell growth factor

Back to article page